Dr. Sergey Yurasov, who just joined Immune Design as the Seattle-based biotech company's chief medical officer and senior vice president of clinical development, said he has always been fascinated by the immune system.
"It’s one of the most efficient systems in world in terms of maintaining what’s happening in the body and now we’re seeing all of these interesting drugs being approved over the last two or three years that focus on unlocking the immune system for cancer patients," he said.…
Dr. Sergey Yurasov, who just joined Immune Design as the Seattle-based biotech company's chief medical officer and senior vice president of clinical development, said he has always been fascinated by the immune system.
"It’s one of the most efficient systems in world in terms of maintaining what’s happening in the body and now we’re seeing all of these interesting drugs being approved over the last two or three years that focus on unlocking the immune system for cancer patients," he said.…